Whitehead Institute scientists report that patients whose estrogen receptor (ER)-positive breast cancers have high levels of the ancient cellular survival factor heat shock factor 1 (HSF1) experience poor outcomes -- including increased mortality. According to the American Cancer Society, approximately two-thirds of breast cancer patients have ER-positive tumors...
More...
Linear Mode
